UZ Antwerp
Welcome,         Profile    Billing    Logout  
 6 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Polyzos, Nikolaos P
DUO_STIM_FRESH, NCT04446845: Double Stimulation Followed by a Fresh Embryo Transfer

Completed
4
120
Europe
Double Stimulation (Elonva+rFSH) in luteal /follicular phase, Conventional Stimulation (Elonva+rFSH) in follicular phase
Fundación Santiago Dexeus Font, Merck Sharp & Dohme LLC
Infertility
01/23
05/23
DUAL-T, NCT04992468 / 2021-002467-22: Dual Trigger for Elective Fertility Preservation

Completed
4
136
Europe
Ovulation triggering with GnRH-a+rhCG, Ovulation triggering with GnRH-a
Fundación Santiago Dexeus Font, Fundación Santiago Dexeus Font
Infertility
04/23
04/23
INTENS-EQ, NCT04983173 / 2021-000941-42: INTEnsity of ovariaN Stimulation and Embryo Quality

Recruiting
4
110
Europe
Ovarian Stimulation with CC+rFSH, Ovarian Stimulation with rFSH
Fundación Santiago Dexeus Font, Fundación Santiago Dexeus Font
Infertility
12/25
06/26
INOVEE, NCT06154083: INtensity of OVarian Stimualtion and Euploid Embryos

Recruiting
4
110
Europe
Follitropin-delta (Rekovelle) 20 mcg/day from D1, Follitropin-delta (Rekovelle) 15 mcg/day from D1
Fundación Santiago Dexeus Font
Fertility
12/25
05/26
PEARL, NCT04719000: PErsonalized Addition of Recombinant LH in Ovarian Stimulation

Recruiting
4
120
Europe
rhFSH+rhLH, rhFSH
Fundación Santiago Dexeus Font, Merck, S.L., Spain
Infertility
08/25
11/25
INFORM, NCT06763926: Intranasal Nafarelin For Triggering Oocyte Maturation

Not yet recruiting
4
134
Europe
Subcutaneous Triptorelin, Intranasal nafarelin
Fundacion Dexeus
Fertility Disorders
01/26
01/26
T-TRANSPORT, NCT02418572 / 2014-001835-35: Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial

Terminated
3
290
Europe
Testosterone gel, Androgel 1% 0.55 gr / day, Placebo gel
Institut Universitari Dexeus
Infertility, Poor Ovarian Response
12/23
02/24
2-Shot, NCT06134479: Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.

Recruiting
3
194
Europe
150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5, 150μg CFA (Elonva®) at SD 1 following by rFSH (Puregon®) 200IU daily from SD 8 until the day of the trigger
Fundación Santiago Dexeus Font, Organon
Fertility
09/25
01/26
MI-PROF, NCT05899010: MIcronized PROgesterone in Frozen Embryo Transfer Cycles

Recruiting
3
1020
Europe
Vaginal progesterone 600mg daily, Vaginal progesterone 800mg daily
Fundación Santiago Dexeus Font
Infertility
06/25
04/26
One-shot, NCT06635538: Ovarian Stimulation Protocol

Recruiting
N/A
20
Europe
Corifollitropin alfa (CFA) 150 mcg + Clomiphene Citrate (CC) 100 mg/day from D1, Clomiphene Citrate (CC) 100 mg/day from D1, Monitoring cycle
Fundación Santiago Dexeus Font
Infertility, Female
04/25
04/25
Tjalma, Wiebren
URODETECT-WP3, NCT05453591: Investigation of Urinary Biomarkers for the Detection of Breast Cancer

Recruiting
N/A
200
Europe
Colli-Pee UAS devices
Novosanis NV, Universiteit Antwerpen
Breast Cancer, Urine, Liquid Biopsy
12/23
04/24
COMBISCREEN, NCT06598176: Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples

Recruiting
N/A
100
Europe
Colli-Pee 20mL device with UCM, Evalyn Brush
Universiteit Antwerpen, University Hospital, Antwerp
Uterine Cervical Neoplasm, Uterine Cervical Dysplasia, Human Papilloma Virus, HPV-Related Cervical Carcinoma
02/27
02/37
Verstraeten, An-Sofie
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Polyzos, Nikolaos P
DUO_STIM_FRESH, NCT04446845: Double Stimulation Followed by a Fresh Embryo Transfer

Completed
4
120
Europe
Double Stimulation (Elonva+rFSH) in luteal /follicular phase, Conventional Stimulation (Elonva+rFSH) in follicular phase
Fundación Santiago Dexeus Font, Merck Sharp & Dohme LLC
Infertility
01/23
05/23
DUAL-T, NCT04992468 / 2021-002467-22: Dual Trigger for Elective Fertility Preservation

Completed
4
136
Europe
Ovulation triggering with GnRH-a+rhCG, Ovulation triggering with GnRH-a
Fundación Santiago Dexeus Font, Fundación Santiago Dexeus Font
Infertility
04/23
04/23
INTENS-EQ, NCT04983173 / 2021-000941-42: INTEnsity of ovariaN Stimulation and Embryo Quality

Recruiting
4
110
Europe
Ovarian Stimulation with CC+rFSH, Ovarian Stimulation with rFSH
Fundación Santiago Dexeus Font, Fundación Santiago Dexeus Font
Infertility
12/25
06/26
INOVEE, NCT06154083: INtensity of OVarian Stimualtion and Euploid Embryos

Recruiting
4
110
Europe
Follitropin-delta (Rekovelle) 20 mcg/day from D1, Follitropin-delta (Rekovelle) 15 mcg/day from D1
Fundación Santiago Dexeus Font
Fertility
12/25
05/26
PEARL, NCT04719000: PErsonalized Addition of Recombinant LH in Ovarian Stimulation

Recruiting
4
120
Europe
rhFSH+rhLH, rhFSH
Fundación Santiago Dexeus Font, Merck, S.L., Spain
Infertility
08/25
11/25
INFORM, NCT06763926: Intranasal Nafarelin For Triggering Oocyte Maturation

Not yet recruiting
4
134
Europe
Subcutaneous Triptorelin, Intranasal nafarelin
Fundacion Dexeus
Fertility Disorders
01/26
01/26
T-TRANSPORT, NCT02418572 / 2014-001835-35: Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial

Terminated
3
290
Europe
Testosterone gel, Androgel 1% 0.55 gr / day, Placebo gel
Institut Universitari Dexeus
Infertility, Poor Ovarian Response
12/23
02/24
2-Shot, NCT06134479: Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.

Recruiting
3
194
Europe
150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5, 150μg CFA (Elonva®) at SD 1 following by rFSH (Puregon®) 200IU daily from SD 8 until the day of the trigger
Fundación Santiago Dexeus Font, Organon
Fertility
09/25
01/26
MI-PROF, NCT05899010: MIcronized PROgesterone in Frozen Embryo Transfer Cycles

Recruiting
3
1020
Europe
Vaginal progesterone 600mg daily, Vaginal progesterone 800mg daily
Fundación Santiago Dexeus Font
Infertility
06/25
04/26
One-shot, NCT06635538: Ovarian Stimulation Protocol

Recruiting
N/A
20
Europe
Corifollitropin alfa (CFA) 150 mcg + Clomiphene Citrate (CC) 100 mg/day from D1, Clomiphene Citrate (CC) 100 mg/day from D1, Monitoring cycle
Fundación Santiago Dexeus Font
Infertility, Female
04/25
04/25
Tjalma, Wiebren
URODETECT-WP3, NCT05453591: Investigation of Urinary Biomarkers for the Detection of Breast Cancer

Recruiting
N/A
200
Europe
Colli-Pee UAS devices
Novosanis NV, Universiteit Antwerpen
Breast Cancer, Urine, Liquid Biopsy
12/23
04/24
COMBISCREEN, NCT06598176: Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples

Recruiting
N/A
100
Europe
Colli-Pee 20mL device with UCM, Evalyn Brush
Universiteit Antwerpen, University Hospital, Antwerp
Uterine Cervical Neoplasm, Uterine Cervical Dysplasia, Human Papilloma Virus, HPV-Related Cervical Carcinoma
02/27
02/37
Verstraeten, An-Sofie
No trials found

Download Options